Pharmaceutical Technology
SEPTEMBER 20, 2022
The study of lifetime exposures, also known as the “exposome”, is providing a new perspective on how environmental and social factors affect disease pathways and general wellbeing, and could influence the way pharma researches drugs.
Bio Pharma Dive
SEPTEMBER 28, 2022
The companies said the drug, called lecanemab, met all of its goals in the Phase 3 study. The data are a significant finding and provide stronger support for a much-debated hypothesis for treating Alzheimer’s
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
SEPTEMBER 30, 2022
By Frank J. Sasinowski & James E. Valentine — On September 29, 2022, FDA approved Amylyx’s NDA for its drug, Relyvrio (sodium phenylbutyrate/taurursodiol), for treatment of patients with amyotrophic lateral sclerosis (ALS) (see FDA announcement here ).
World of DTC Marketing
SEPTEMBER 7, 2022
Wall Street wants growth, as do investors, but that may be impossible for pharmaceutical companies. In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharma Mirror
SEPTEMBER 16, 2022
Barcelon, a global biopharmaceutical company focused on skin health, announced at the 31st EADV (European Association of Dermatology and Venereology) Congress the results from TRIBUTE, an interventional phase IV clinical study, which resembled real-life clinical practice. In this study, Ilumetri®?
The Pharma Data
SEPTEMBER 30, 2022
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
SEPTEMBER 30, 2022
The drug, which will be sold as Relyvrio, showed modest benefits in function and survival in testing. It also became the latest test of the FDA's flexibility toward new therapies for neurological disorders
Pharma Times
SEPTEMBER 21, 2022
A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial
World of DTC Marketing
SEPTEMBER 12, 2022
Apple’s Health app gets new capabilities with iOS 16. The Health app adds Medications, allowing users to conveniently build and manage a medications list, create schedules and reminders, and track their medications, vitamins, or supplements. Will it matter?
Pharma Mirror
SEPTEMBER 16, 2022
Waiblingen/Germany, The Syntegon Group, a globally leadingsupplier of processing and packaging technology, intends to appoint Dr. Peter Hackelas member of the Executive Board at the beginning of 2023.
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharmaceutical Technology
SEPTEMBER 22, 2022
It is the year 2030. You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer.
Bio Pharma Dive
SEPTEMBER 30, 2022
The application comes a year earlier than previously had been expected, as company says drug reviewers are open to accelerated review based on data from early-stage trials
Pharmaceutical Commerce
SEPTEMBER 26, 2022
New facility will focus on company’s temperature-controlled pallet shipper rental program.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Intouch Solutions
SEPTEMBER 23, 2022
Faruk Capan Named Advertising Agency CEO of the Year in PM360 Trailblazer Awards. KANSAS CITY – Sept.
Pharma Mirror
SEPTEMBER 16, 2022
REHOVOT, Israel & WILMINGTON Ayala Pharmaceuticals, Inc.
The Pharma Data
SEPTEMBER 28, 2022
The first large, real- world study of the effectiveness of mRNA COVID- 19 vaccines during gestation set up these vaccines, especially two original boluses followed by a supporter, are effective in guarding against serious complaint in expectant maters whether the shots are administered before or during gestation.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Tetra Bio-Pharma and Cellvera have entered an agreement to jointly develop ARDS-003 as an oral combination therapeutic candidate with 400mg Qifenda (Favipiravir) for Covid-19. A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez.
Bio Pharma Dive
SEPTEMBER 17, 2022
The therapy, called Skysona and cleared to treat cerebral adrenoleukodystrophy, is the product of more than a decade of work by Bluebird. It will cost $3 million
Elsevier
SEPTEMBER 12, 2022
Thanks to new and innovative treatments, cancer survival rates continue to improve dramatically – and this will likely only accelerate in the future.
Intouch Solutions
SEPTEMBER 20, 2022
When you’re looking at keywords, how do you know if you’re seeing everything that’s out there? Sadly, you probably aren’t. No tool is perfect. But which one is best?
Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
The Pharma Data
SEPTEMBER 29, 2022
Dupixent ®( dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Dupixent significantly reduced itch and skin lesions compared to placebo in direct- to- Phase 3 program conforming of two vital trials About,000 grown-ups in theU.S.
Pharmaceutical Technology
SEPTEMBER 5, 2022
Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We We want to be a sustainably growing company.
Bio Pharma Dive
SEPTEMBER 2, 2022
Preliminary results from a Phase 1 study show Sangamo’s treatment to be safe and suggest it is working as intended, leading the biotech to move into the trial’s next phase
Pharmaceutical Commerce
SEPTEMBER 14, 2022
Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable.
Pharma Times
SEPTEMBER 26, 2022
The study will focus on checkpoint inhibitor refractory non-small cell lung cancer
Pharma Mirror
SEPTEMBER 9, 2022
Cambridge, UK: STORM Therapeutics Ltd.
The Pharma Data
SEPTEMBER 29, 2022
Glioblastoma, the most common cancerous brain excrescence in grown-ups, is an aggressive complaint- cases survive an normal of just 15 months once they’re diagnosed.
Pharmaceutical Technology
SEPTEMBER 30, 2022
After several setbacks, bluebird bio bounces back with two major FDA gene therapy approvals. Last month, Zynteglo (betibeglogene autotemcel), or beti-cel, was approved as a one-time potentially curative gene therapy for patients with beta-thalassaemia who require regular blood transfusions.
Bio Pharma Dive
SEPTEMBER 16, 2022
The public-private partnership plans to bring together scientific experts, private entities and patient groups to better understand certain neurodegenerative disorders and find new treatments
BioPharma Reporter
SEPTEMBER 1, 2022
Arcturus Therapeutics has obtained an award for up to $63.2m
Pharma Times
SEPTEMBER 12, 2022
Collaboration will involve sophisticated screening for cardiac-based drug discovery
Pharma Phorum
SEPTEMBER 5, 2022
Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised.
Expert insights. Personalized for you.
280 
Let's personalize your content